By Lisa Kerner
Erie, Pa., March 21 - Magen BioSciences, Inc. said it secured $1.8 million in a seed investment round.
ARCH Venture Partners, TVM Capital and Venrock Associates co-led the financing. Alexandria Real Estate and Lux Capital also participated in the round.
Steven Gillis, venture partner of ARCH Venture Partners, and Stephen Hoffman, general partner of TVM Capital, will join Magen's board of directors.
Located in Boston, Magen is focused on promoting the health and appearance of human skin.
| Issuer: | Magen BioSciences, Inc.
|
| Issue: | Seed financing
|
| Amount: | $1.8 million
|
| Investors: | ARCH Venture Partners, TVM Capital and Venrock Associates (co-leads), Alexandria Real Estate, Lux Capital
|
| Announcement date: | March 21
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
